192 related articles for article (PubMed ID: 21572317)
41. ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats.
Wang B; Chen S; Yang J; Yang L; Liu J; Zhang W
PLoS One; 2017; 12(8):e0183439. PubMed ID: 28813523
[TBL] [Abstract][Full Text] [Related]
42. Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema.
Levy ML; Aranda M; Zelman V; Giannotta SL
Neurosurgery; 1995 Aug; 37(2):363-9; discussion 369-71. PubMed ID: 7477798
[TBL] [Abstract][Full Text] [Related]
43. [Quality of induction and adrenocortical function. A clinical comparison of Etomidate-Lipuro and Hypnomidate].
Vanacker B; Wiebalck A; Van Aken H; Sermeus L; Bouillon R; Amery A
Anaesthesist; 1993 Feb; 42(2):81-9. PubMed ID: 8470789
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of corticosteroidogenesis by etomidate.
Goverde HJ; Boidin MP; Zandstra DF; Agoston S
Acta Anaesthesiol Belg; 1985 Dec; 36(4):375-80. PubMed ID: 3006419
[TBL] [Abstract][Full Text] [Related]
45. Etomidate infusion and adrenocortical function. A study in elective surgery.
Wanscher M; Tønnesen E; Hüttel M; Larsen K
Acta Anaesthesiol Scand; 1985 Jul; 29(5):483-5. PubMed ID: 4036533
[TBL] [Abstract][Full Text] [Related]
46. The effect of repeated etomidate anesthesia on adrenocortical function during a course of electroconvulsive therapy.
Wang N; Wang XH; Lu J; Zhang JY
J ECT; 2011 Dec; 27(4):281-5. PubMed ID: 22080238
[TBL] [Abstract][Full Text] [Related]
47. Duration of etomidate-induced adrenocortical suppression during surgery in dogs.
Dodam JR; Kruse-Elliott KT; Aucoin DP; Swanson CR
Am J Vet Res; 1990 May; 51(5):786-8. PubMed ID: 2337278
[TBL] [Abstract][Full Text] [Related]
48. Quantitation of the EEG and pharmacodynamic modelling of hypnotic drugs: etomidate as an example.
Schwilden H; Schüttler J; Stoeckel H
Eur J Anaesthesiol; 1985 Jun; 2(2):121-31. PubMed ID: 4029126
[TBL] [Abstract][Full Text] [Related]
49. The pharmacology of cyclopropyl-methoxycarbonyl metomidate: a comparison with propofol.
Ge R; Pejo E; Gallin H; Jeffrey S; Cotten JF; Raines DE
Anesth Analg; 2014 Mar; 118(3):563-7. PubMed ID: 24557104
[TBL] [Abstract][Full Text] [Related]
50. Quantifying the interaction of rocuronium (Org 9426) with etomidate, fentanyl, midazolam, propofol, thiopental, and isoflurane using closed-loop feedback control of rocuronium infusion.
Olkkola KT; Tammisto T
Anesth Analg; 1994 Apr; 78(4):691-6. PubMed ID: 8135387
[TBL] [Abstract][Full Text] [Related]
51. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.
Schulte HM; Benker G; Reinwein D; Sippell WG; Allolio B
J Clin Endocrinol Metab; 1990 May; 70(5):1426-30. PubMed ID: 2159485
[TBL] [Abstract][Full Text] [Related]
52. The effects of a competitive antagonist on GABA-evoked currents in the presence of sedative-hypnotic agents.
McGrath M; Tolia M; Raines DE
Pharmacol Rep; 2020 Feb; 72(1):260-266. PubMed ID: 32016849
[TBL] [Abstract][Full Text] [Related]
53. The effect of etomidate on adrenocortical function in dogs before and during hemorrhagic shock.
Fraser R; Watt I; Gray CE; Ledingham IM; Lever AF
Endocrinology; 1984 Dec; 115(6):2266-70. PubMed ID: 6094155
[TBL] [Abstract][Full Text] [Related]
54. Combined Use of Etomidate and Dexmedetomidine Produces an Additive Effect in Inhibiting the Secretion of Human Adrenocortical Hormones.
Gu H; Zhang M; Cai M; Liu J
Med Sci Monit; 2015 Nov; 21():3528-35. PubMed ID: 26568275
[TBL] [Abstract][Full Text] [Related]
55. Effect of etomidate on adrenal function in rats.
Hampl R; Bicíková M; Motlík K; Stárka L
Endocrinol Exp; 1987 Sep; 21(3):229-35. PubMed ID: 3499308
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetic-pharmacodynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers.
Hering WJ; Ihmsen H; Langer H; Uhrlau C; Dinkel M; Geisslinger G; Schüttler J
Anesthesiology; 1996 Dec; 85(6):1290-9. PubMed ID: 8968176
[TBL] [Abstract][Full Text] [Related]
57. Clinical and molecular pharmacology of etomidate.
Forman SA
Anesthesiology; 2011 Mar; 114(3):695-707. PubMed ID: 21263301
[TBL] [Abstract][Full Text] [Related]
58. Acute etomidate treatment reduces cognitive deficits and histopathology in rats with traumatic brain injury.
Dixon CE; Ma X; Kline AE; Yan HQ; Ferimer H; Kochanek PM; Wisniewski SR; Jenkins LW; Marion DW
Crit Care Med; 2003 Aug; 31(8):2222-7. PubMed ID: 12973183
[TBL] [Abstract][Full Text] [Related]
59. Adrenocortical suppression and other endocrine effects of etomidate.
Preziosi P; Vacca M
Life Sci; 1988; 42(5):477-89. PubMed ID: 3276997
[TBL] [Abstract][Full Text] [Related]
60. Carboetomidate: an analog of etomidate that interacts weakly with 11β-hydroxylase.
Shanmugasundararaj S; Zhou X; Neunzig J; Bernhardt R; Cotten JF; Ge R; Miller KW; Raines DE
Anesth Analg; 2013 Jun; 116(6):1249-56. PubMed ID: 23492967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
